Holley F O, Ponganis K V, Stanski D R
Clin Pharmacol Ther. 1984 May;35(5):617-26. doi: 10.1038/clpt.1984.85.
We investigated lidocaine kinetics after cardiac surgery to elucidate the effects of cardiopulmonary bypass (CPB) and major surgery on its disposition. In five patients lidocaine kinetics were unchanged 15 min and 1 day after CPB, but lidocaine clearance decreased 42% and volume of distribution was reduced by 40% in eight patients 3 days after surgery. Seven days after surgery lidocaine kinetics had returned to baseline in five patients. These changes correlated with a doubling of the alpha 1-acid glycoprotein concentration and a 46% decrease in lidocaine free fraction on day 3, effects that persisted on day 7. Our results suggest that the use of lidocaine need not be altered in the first day after uncomplicated coronary artery surgery, but, in light of our findings the use of lidocaine and the interpretation of measured total lidocaine concentrations 3 to 7 days thereafter should be reexamined.
我们研究了心脏手术后利多卡因的动力学,以阐明体外循环(CPB)和大手术对其处置的影响。五名患者在CPB后15分钟和1天时利多卡因动力学未发生变化,但八名患者在术后3天时利多卡因清除率降低了42%,分布容积减少了40%。术后7天时,五名患者的利多卡因动力学已恢复至基线水平。这些变化与第3天α1-酸性糖蛋白浓度加倍以及利多卡因游离分数降低46%相关,这些影响在第7天仍然存在。我们的结果表明,在无并发症的冠状动脉手术后第一天,利多卡因的使用无需改变,但鉴于我们的研究结果,此后3至7天利多卡因的使用以及所测总利多卡因浓度的解释应重新审视。